# Aligos Therapeutics, Inc.: Form 8-K, filed May 31, 2024

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2024-05-31
- Accepted by EDGAR: May 31, 2024, 16:05 ET
- Period: 2024-05-29
- Accession: 0001193125-24-151729
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312524151729/d808483d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312524151729/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312524151729/d808483d8k.htm

Filed May 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-151729. Last ingested by Listed: Nov 14, 2026, 12:59 ET. No prices; not investment advice.
